Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of the combination of mitoxantrone and
granulocyte-macrophage colony stimulating factor (GM-CSF) on progression-free survival (PFS)
and overall survival (OS), in patients with hormone-refractory prostate cancer.